Notice Pursuant to the National Cooperative Research and Production Act of 1993-American Society of Health-System Pharmacists, 8823 [05-3437]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 35 / Wednesday, February 23, 2005 / Notices
8823
3752 (February 2005), entitled Outboard
Engines from Japan: Investigation No.
731–TA–1069 (Final).
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Antitrust Division
Antitrust Division
Issued: February 17, 2005.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 05–3415 Filed 2–22–05; 8:45 am]
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—United States Adopted
Names Council
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—VSI Alliance
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—American Society of
Health-System Pharmacists
Notice is hereby given that, on
September 9, 2004, pursuant to section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
American Society of Health-System
Pharmacists (‘‘ASHP’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing (1) the name and
principal place of business of the
standards development organization
and (2) the nature and scope of its
standards development activities. The
notifications were filed for the purpose
of invoking Act’s provisions limiting the
recovery of antitrust plaintiffs to actual
damages under specified circumstances.
Pursuant to section 6(b) of the Act, the
name and principal place of business of
the standards development organization
is: American Society of Health-System
Pharmacists, Bethesda, MD. The nature
and scope of ASHP’s standards
development activities are: The
publication of guidance documents of
varying scope that provide ongoing
advice to pharmacy practitioners and
health-systems to improve the
medication use process, patient care and
safety, and patient outcomes and quality
of life.
Dorothy B. Fountain,
Deputy Director of Operations, Antitrust
Division.
[FR Doc. 05–3437 Filed 2–22–05; 8:45 am]
BILLING CODE 4410–11–M
Notice is hereby given that, on
September 17, 2004, pursuant to section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
United States Adopted Names Council
(‘‘USAN’’) on behalf of itself and its
sponsors has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing (1) the name and
principal place of business of the
standards development organization
and (2) the nature and scope of its
standards development activities. The
notifications were filed for the purpose
of invoking the Act’s provisions limiting
the recovery of antitrust plaintiffs to
actual damages under specified
circumstances.
Pursuant to section 6(b) of the Act, the
name and principal place of business of
the standards development organization
is: United States Adopted Names
Council, Chicago, IL. The nature and
scope of USAN’s standards
development activities are: The
development of standards for simple
and unique nonproprietary names for
drugs by establishing logical
nomenclature classifications based on
pharmacological and/or chemical
relationships. The USAN is sponsored
by the American Medical Association,
the American Pharmacists Association,
and United States Pharmacopeia. USAN
works closely with the World Health
Organization International
Nonproprietary Name Committee (INN)
and various national nomenclature
groups to develop global
standardization and unification of drug
nomenclature and related rules to
ensure that drug information is
communicated accurately and
unambiguously.
Dorothy B. Fountain,
Deputy Director of Operations, Antitrust
Division.
[FR Doc. 05–3438 Filed 2–22–05; 8:45 am]
BILLING CODE 4410–11–M
VerDate jul<14>2003
16:28 Feb 22, 2005
Jkt 205001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Notice is hereby given that, on
January 19, 2005, pursuant to section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’), the
VSI Alliance has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Agere Systems, Inc.,
Allentown, PA; ARC International PLC,
Nashua, NH; CNRS-Centre National De
Recherche Scientifique, Paris, France;
ControlNet, Inc., Campbell, CA; Design
and Reuse, Grenoble, France; eSilicon
Corp., Sunnyvale, CA; Fraunhofer IPMS,
Dresden, Germany; HCL Technologies
Indian Pvt., Ltd., Chennai, India; ITRIIndustrial Technology Research
Institute, Hsinchu, Taiwan; Jet
Propulsion Laboratory, Pasadena, CA;
Macronix International Company, Ltd.,
Hsinchu, Taiwan; M–Techno Structure
IT-Solution GMBH, Vienna, Austria;
Morpho Technologies, Irvine, CA;
NewLogic Technologies AG, Lustenau,
Austria; Renesas Technology
Corporation, Tokyo, Japan; Sanyo LSI
Technology, India Pvt. Ltd., Bangalore,
India; SilTerra Malaysia Sdu. Bhd.,
Sunnyvale, CA; Synchronicity, Inc.,
Marlboro, MA; TaraCom Integrated
Products, Sunnyvale, CA; Tower
Semiconductor, Ltd., Migdal Haemek,
Israel; VCX, Limited, Livingston,
Scotland, United Kingdom; WIS
Technologies, San Jose, CA; and Xignal
Technologies, AG Unterhaching,
Germany have withdrawn as parties to
this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and VSI Alliance
intends to file additional written
notification disclosing all changes in
membership.
On November 29, 1996, VSI Alliance
filed its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on March 4, 1997 (62 FR
9812).
E:\FR\FM\23FEN1.SGM
23FEN1
]]>Agencies
[Federal Register Volume 70, Number 35 (Wednesday, February 23, 2005)]
[Notices]
[Page 8823]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-3437]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--American Society of Health-System Pharmacists
Notice is hereby given that, on September 9, 2004, pursuant to
section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), American Society of Health-
System Pharmacists (``ASHP'') has filed written notifications
simultaneously with the Attorney General and the Federal Trade
Commission disclosing (1) the name and principal place of business of
the standards development organization and (2) the nature and scope of
its standards development activities. The notifications were filed for
the purpose of invoking Act's provisions limiting the recovery of
antitrust plaintiffs to actual damages under specified circumstances.
Pursuant to section 6(b) of the Act, the name and principal place
of business of the standards development organization is: American
Society of Health-System Pharmacists, Bethesda, MD. The nature and
scope of ASHP's standards development activities are: The publication
of guidance documents of varying scope that provide ongoing advice to
pharmacy practitioners and health-systems to improve the medication use
process, patient care and safety, and patient outcomes and quality of
life.
Dorothy B. Fountain,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 05-3437 Filed 2-22-05; 8:45 am]
BILLING CODE 4410-11-M
